Related Experiment Video
Updated: Jun 25, 2025
07:29
Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
9.3K
Pleiotropic functions and clinical importance of circulating HDL-PON1 complex.
1Immunogenetics Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran; Department of Clinical Biochemistry and Medical Genetics, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Advances in Clinical Chemistry
|May 26, 2024
Summary
High density lipoprotein (HDL) enzyme paraoxonase 1 (PON1) is crucial for HDL
Area of Science:
- Biochemistry
- Cardiovascular Research
- Enzymology
Background:
- High density lipoprotein (HDL) functionality relies on its associated proteome, especially enzymes.
- Paraoxonase 1 (PON1) is abundant in HDL particles and significantly contributes to HDL's antioxidant and antiatherogenic properties.
- Assessing HDL function reliably in clinical settings requires validated methods, with HDL-associated proteins like PON1 being key candidates.
Purpose of the Study:
- To review biochemical and clinical evidence on the interactions between PON1 and HDL.
- To explore PON1's role as a biomarker for HDL function.
- To discuss PON1 as a potential therapeutic target for HDL-related conditions.
Main Methods:
- Review of existing biochemical and clinical studies on HDL-PON1 interactions.
- Analysis of PON1 activity assays, particularly arylesterase activity.
- Examination of the role of apolipoprotein A-I in HDL-PON1 binding and function.
Main Results:
- PON1 binding to HDL is essential for maintaining its enzymatic activity.
- Apolipoprotein A-I plays a significant role in the interaction between HDL and PON1.
- Decreased PON1 activity is linked to HDL dysfunctionality and increased cardiovascular risk.
Conclusions:
- PON1's arylesterase activity is a promising biomarker for HDL functionality.
- Understanding HDL-PON1 interactions is critical for developing new therapeutic strategies.
- Automated assays for PON1 activity facilitate its use in large-scale studies and clinical practice.
Related Concept Videos
01:31Lipid-derived Compounds in the Human Body
4.4K
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
4.4K
01:33Pleiotropy
40.4K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
40.4K
01:07Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
38
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
38
01:22Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
01:27Nonlinear Pharmacokinetics: Role of Transporters
47
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
47
01:24Peroxisomes
12.1K
Peroxisomes are specialized organelles present in fungi, plant, and animal cells. It can vary in number, size, morphology, and activity depending on the type of tissue and the nutritional state of the cell. For example, cells with active lipid metabolism, such as adipocytes, neurons, and hepatocytes, have more peroxisomes than other cells in the body. Besides their primary role in breaking down complex organic molecules, peroxisomes can also synthesize specific macromolecules and participate in...
12.1K